Search clinical trials for: No treatment given

Total 18110 results

Robert G. Grossman, MD
The University of Texas Health Science Center, Houston; University of Maryland... and other collaborators

Recruiting

Spinal Cord Injury Registry - North American Clinical Trials Network (NACTN)

Spinal Cord Injury

United States, Canada
Novo Nordisk A/S

Enrolling by invitation

A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Systemic Inflammation | Chronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)

United States
Novo Nordisk A/S

Enrolling by invitation

Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) (POSEIDON)

Heart Failure | Chronic Kidney Disease | Cardiovascular Risk

Korea, Republic of, China, United States, Argentina, Germany, Canada, Poland, Brazil
Novo Nordisk A/S

Enrolling by invitation

An Observational Study of Patients With Moderate Parkinson's Disease (TRANSCEND 1)

Parkinson Disease

United States, Japan, Sweden, United Kingdom
Novo Nordisk A/S

Completed

A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland (ExplorEUEast)

Obesity

Poland, Czechia, Hungary
Novo Nordisk A/S

Completed

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey (BARRIERS-MASLD)

Non-alcoholic Steatohepatitis (MASH) | Non-alcoholic Fatty Liver Disease (MASLD)

India
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management (ACTION-France)

Obesity

France
Novo Nordisk A/S

Completed

Attitudes and Unmet Needs Among Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of, Mexico, India, United Kingdom, Australia, France, Saudi Arabia
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China (ACTION China)

Obesity

China
Novo Nordisk A/S

Completed

Diabetes Attitudes Wishes and Needs (DAWN2)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Relatives to/Carers of Patients | Healthcare Professionals

Spain, Algeria, China, India, Mexico, Russian Federation, Turkey, Germany, Poland, Japan, Netherlands, Italy, Canada, United Kingdom, Denmark, France, United States
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India (DiabCare India)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

India
Novo Nordisk A/S

Completed

Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (HAEMOcare)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

India, Morocco, South Africa, Oman
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Malaysia
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Singapore
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Bangladesh
Novo Nordisk A/S

Completed

Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

Healthy | Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Enrolling by invitation

Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational Study

Obesity

Kuwait, Oman, Qatar
Novo Nordisk A/S

Completed

Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi Arabia (OCCURS)

Obesity and Cardiovascular Risk

Saudi Arabia
Novo Nordisk A/S

Enrolling by invitation

A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease. (POETIC)

Obesity | Overweight

United States, Saudi Arabia, Brazil, Canada, Spain
Novo Nordisk A/S

Completed

A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists (FLAME-ASCVD)

Chronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)

India
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland (ACTION-CH)

Obesity

Switzerland
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens) (ACTION Teens)

Obesity

Spain, Turkey, Italy, Taiwan, Australia, Colombia, Korea, Republic of, Mexico, Saudi Arabia, United Kingdom
Novo Nordisk A/S

Completed

A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal (PICT2RE)

Diabetes Mellitus, Type 2

Portugal
Novo Nordisk A/S

Completed

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes

Vietnam
Novo Nordisk A/S

Completed

Awareness, Care & Treatment in Obesity Management (ACTION) Study (ACTION)

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Awareness, Care and Treatment in Obesity Management

Obesity | Metabolism and Nutrition Disorder

Canada
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management - An International Observation (ACTION-IO)

Obesity

United Arab Emirates, Australia, Israel, Korea, Republic of, Mexico, Saudi Arabia, Spain, Switzerland, United Kingdom
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 Diabetes (Diabcare)

Diabetes | Diabetes Mellitus, Type 1

Algeria
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Thailand
Novo Nordisk A/S

Completed

To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives (HERO)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of Patients

Brazil
Novo Nordisk A/S

Completed

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes

Malaysia
Novo Nordisk A/S

Completed

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes

Indonesia
Novo Nordisk A/S

Recruiting

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial (SELECT-LIFE)

Obesity | Overweight

Brazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Philippines
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Korea, Republic of
Novo Nordisk A/S

Completed

Persons With Obesity (PwO) Exploratory Research

Obesity

India
Novo Nordisk A/S

Completed

An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa (PACT-MEA)

Diabetes Mellitus, Type 2

Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, United Arab Emirates
Novo Nordisk A/S

Completed

Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific (ACTION-APAC)

Obesity

Pakistan, Bangladesh, India, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam
Novo Nordisk A/S

Completed

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

United States, Serbia, Malaysia, Thailand, Greece, Japan, Romania
Novo Nordisk A/S

Completed

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE) (ACTION to HOPE)

Haemophilia A, Haemophilia B, Obesity

United States
Novo Nordisk A/S

Completed

Survey Evaluating the Psychosocial Effects of Living With Haemophilia (HERO)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of Patients

Spain, Canada, United Kingdom
Novo Nordisk A/S

Completed

Changing Diabetes® World Tour

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

United Arab Emirates, Saudi Arabia, Portugal
Novo Nordisk A/S

Completed

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

United States
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Taiwan
Novo Nordisk A/S

Completed

Project to Update the Study of Congenital Haemophilia in Spain (PUCHS)

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Spain
Novo Nordisk A/S

Completed

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes

Bangladesh
Novo Nordisk A/S

Withdrawn

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes
Novo Nordisk A/S

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia (DiabCare Asia)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Indonesia
Novo Nordisk A/S

Completed

Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender (ASPECT - APAC)

Obesity | Overweight

United Arab Emirates

3

Subscribe